Blog

Introduction

Ovarian cancer is known for its high recurrence rate and complex metastatic patterns, often involving lymph nodes, peritoneum, omentum, and distant sites. Accurate assessment of disease progression after surgery and chemotherapy is critical for guiding further oncologic management.

68Ga-FAPI PET-CT, a novel molecular imaging modality targeting cancer-associated fibroblasts, has shown superior sensitivity in detecting recurrent and metastatic ovarian cancer, especially in the peritoneum and lymph nodes.

This case highlights the clinical value of 68Ga-FAPI PET-CT in identifying disease progression in a treated ovarian cancer patient

Introduction

Breast cancer remains one of the most common malignancies among women worldwide. Early detection and accurate staging play a crucial role in treatment planning and improving patient outcomes. F-18 FDG PET-CT scan has emerged as a powerful diagnostic tool that not only detects the primary tumor but also identifies nodal and distant metastases in a single whole-body evaluation.

This case demonstrates how FDG PET-CT changed the staging and management plan of a breast cancer patient, emphasizing its value as a one-stop solution in oncology.